528 related articles for article (PubMed ID: 32450921)
1. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.
Rades D; Narvaez CA; Doemer C; Janssen S; Olbrich D; Tvilsted S; Conde-Moreno AJ; Cacicedo J
Trials; 2020 May; 21(1):424. PubMed ID: 32450921
[TBL] [Abstract][Full Text] [Related]
2. Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02).
Rades D; Zwaan I; Cacicedo J; Bruchhage KL; Hakim SG; Olbrich D; Schild SE; Tvilsted S; Janssen S
BMC Cancer; 2022 Sep; 22(1):989. PubMed ID: 36115962
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.
Huang CJ; Huang MY; Fang PT; Chen F; Wang YT; Chen CH; Yuan SS; Huang CM; Luo KH; Chuang HY; Wang YY; Lee HH
Am J Clin Nutr; 2019 Mar; 109(3):606-614. PubMed ID: 30753262
[TBL] [Abstract][Full Text] [Related]
6. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
7. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
8. Serum zinc status and the development of mucositis and dermatitis in head-and-neck cancer patients undergoing curative radiotherapy: A pilot study.
Rao S; Kalekhan F; Hegde SK; Rao P; Suresh S; Baliga MS
J Cancer Res Ther; 2022; 18(1):42-48. PubMed ID: 35381760
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
Burdelya LG; Gleiberman AS; Toshkov I; Aygun-Sunar S; Bapardekar M; Manderscheid-Kern P; Bellnier D; Krivokrysenko VI; Feinstein E; Gudkov AV
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):228-34. PubMed ID: 22000579
[TBL] [Abstract][Full Text] [Related]
10. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
11. A network meta-analysis in comparing prophylactic treatments of radiotherapy-induced oral mucositis for patients with head and neck cancers receiving radiotherapy.
Peng H; Chen BB; Chen L; Chen YP; Liu X; Tang LL; Mao YP; Li WF; Zhang Y; Lin AH; Sun Y; Ma J
Oral Oncol; 2017 Dec; 75():89-94. PubMed ID: 29224830
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Kanglaite against radiotherapy-induced mucositis in head and neck cancer, a phase II trial.
Liu ZP; Song QY; Chu CL; Liu SH; Ren YX; Chen J; Zhang DX
Cancer Radiother; 2022 Jun; 26(4):585-593. PubMed ID: 35210179
[TBL] [Abstract][Full Text] [Related]
13. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.
Soni TP; Gupta AK; Sharma LM; Singhal H; Sharma S; Gothwal RS
ORL J Otorhinolaryngol Relat Spec; 2022; 84(2):103-113. PubMed ID: 34161952
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
[TBL] [Abstract][Full Text] [Related]
16. The effect of the use of thyme honey in minimizing radiation - induced oral mucositis in head and neck cancer patients: A randomized controlled trial.
Charalambous M; Raftopoulos V; Paikousis L; Katodritis N; Lambrinou E; Vomvas D; Georgiou M; Charalambous A
Eur J Oncol Nurs; 2018 Jun; 34():89-97. PubMed ID: 29784145
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
[TBL] [Abstract][Full Text] [Related]
18. A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy.
Long X; Guo J; Yin Y; Cheng M; Zhang X; Zhang J; Wang P; Zang J; Zhao L
Radiat Oncol; 2023 Oct; 18(1):174. PubMed ID: 37891689
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
Sayed R; El Wakeel L; Saad AS; Kelany M; El-Hamamsy M
Med Oncol; 2019 Nov; 37(1):8. PubMed ID: 31748905
[TBL] [Abstract][Full Text] [Related]
20. Effect of low level helium-neon (He-Ne) laser therapy in the prevention & treatment of radiation induced mucositis in head & neck cancer patients.
Arun Maiya G; Sagar MS; Fernandes D
Indian J Med Res; 2006 Oct; 124(4):399-402. PubMed ID: 17159259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
